The kinetics of the killing of mouse tumour cells in vivo by immune responses
β Scribed by D. D. Porteous; T. R. Munro
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- French
- Weight
- 404 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Immune responses against the C3H mouse ascites tumour BP8 were studied in vivo by measuring the proportion of an inoculum that was killed in allogeneic C57BL animals. Killing was assayed by labelling the cells with ^125^IUdR; the ^125^I liberated from dead cells was excreted, and the proportion of label (and thus the proportion of cells) remaining was measured by wholeβbody counting. Cell loss from the primary immune response began about a week after intraperitoneal injection of 10^7^ cells, and was accelerated by addition of 10^7^β10^8^ heavily irradiated cells to the inoculum. By contrast, it began immediately in immunized mice. Labelled cells irradiated with 10,000 R of Xβrays did not begin to lose ^125^I until 2 days after irradiation, and so could be used to investigate the immune status of an animal without fear of killing it.
π SIMILAR VOLUMES
## Abstract Normal and primed spleen cells stimulated __in vitro__ with sheep RBC showed a different behaviour in the 19 S PFC response. The immunologic capacity of primed cells, unlike that of unprimed cells, was impaired if the antigen addition to culture had been delayed for more than six hours.
Direct delivery of the herpes simplex virus thymidine kinase (HSVtk) gene, in combination with the prodrug ganciclovir (GC), has been used for the treatment of localised, inoperable tumours. Several groups have shown that when rodent tumours are ablated in vivo with suicide genes, anti-tumour immuni
## Abstract Steadyβstate dendritic cells (DC) present peptideβMHC complexes to T cells in a tolerogenic manner, presumably because of deficient costimulation. However, it is clear that the path to tolerance involves initial T cell activation, suggesting that the deficit may lie in lateβacting costi